[go: up one dir, main page]

BR9912051A - Uso de composto, e, processo para tratamento e prevenção de discinesia. - Google Patents

Uso de composto, e, processo para tratamento e prevenção de discinesia.

Info

Publication number
BR9912051A
BR9912051A BR9912051-8A BR9912051A BR9912051A BR 9912051 A BR9912051 A BR 9912051A BR 9912051 A BR9912051 A BR 9912051A BR 9912051 A BR9912051 A BR 9912051A
Authority
BR
Brazil
Prior art keywords
dyskinesia
prevention
treatment
compost
dystonia
Prior art date
Application number
BR9912051-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Ross Nicholas Waters
Clas Ke Sonesson
Arvid Carlsson
Original Assignee
Carlsson A Research Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carlsson A Research Ab filed Critical Carlsson A Research Ab
Publication of BR9912051A publication Critical patent/BR9912051A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hydrogenated Pyridines (AREA)
BR9912051-8A 1998-07-15 1999-07-15 Uso de composto, e, processo para tratamento e prevenção de discinesia. BR9912051A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9802546A SE9802546D0 (sv) 1998-07-15 1998-07-15 Medicinal product and method for treatment and prevention of dyskinesia
PCT/SE1999/001274 WO2000003714A1 (fr) 1998-07-15 1999-07-15 Produit medicinal et procede de traitement et de prevention de la dyskinesie

Publications (1)

Publication Number Publication Date
BR9912051A true BR9912051A (pt) 2001-04-03

Family

ID=20412091

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9912051-8A BR9912051A (pt) 1998-07-15 1999-07-15 Uso de composto, e, processo para tratamento e prevenção de discinesia.

Country Status (7)

Country Link
EP (1) EP1096935A1 (fr)
JP (1) JP2002520361A (fr)
AU (1) AU5456899A (fr)
BR (1) BR9912051A (fr)
CA (1) CA2336998A1 (fr)
SE (1) SE9802546D0 (fr)
WO (1) WO2000003714A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE46117E1 (en) 1999-12-22 2016-08-23 Teva Pharmaceuticals International Gmbh Modulators of dopamine neurotransmission
GB0002100D0 (en) * 2000-01-28 2000-03-22 Novartis Ag Organic compounds
EP1404326A4 (fr) * 2000-10-12 2004-06-30 Upjohn Co Methode de traitement de la maladie de parkinson
AR031152A1 (es) 2000-10-31 2003-09-10 Upjohn Co Tratamientos nuevos para el sindrome de piernas inquietas
US6670378B2 (en) * 2001-05-08 2003-12-30 Pharmacia & Upjohn Company Method of treating Parkinson's disease
DK2618826T3 (en) * 2010-09-20 2016-08-01 A Carlsson Res Ab Phenylpiperdine FOR TREATMENT OF DEMENTIA

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6135175B2 (fr) * 1979-12-05 1986-08-12 Astra Laekemedel Ab
US4937346A (en) * 1979-12-05 1990-06-26 Per Arvid Emil Carlsson Phenyl-azacykloalkanes
US4719219A (en) * 1982-03-30 1988-01-12 Per A. E. Carlsson Phenyl-azacycloalkanes and use thereof in treatment of central nervous system disorders

Also Published As

Publication number Publication date
EP1096935A1 (fr) 2001-05-09
CA2336998A1 (fr) 2000-01-27
WO2000003714A1 (fr) 2000-01-27
JP2002520361A (ja) 2002-07-09
AU5456899A (en) 2000-02-07
SE9802546D0 (sv) 1998-07-15

Similar Documents

Publication Publication Date Title
BR0114321A (pt) Composto, composição farmacêutica, uso de um composto, método de tratamento ou profilaxia de doenças inflamatórias, e, processo para preparar um composto
BR9914696A (pt) Composto, processo para tratamento de distúrbio mediado por ciclo-oxigenase-2 em um indivìduo, e, composição farmacêutica
BR0112224A (pt) Composto, composição farmacêutica, uso de um composto ou de um sal, solvato ou pró-droga farmaceuticamente aceitável do mesmo, e, processo para preparar um composto
BG103945A (en) Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a
IL171977A (en) Cyclic sulfonamide for inhibition of gamma-secretase, process for its preparation and a pharmaceutical composition comprising the same
MY130668A (en) Isothiazole derivatives useful as anticancer agents
BR0209821A (pt) Compostos, processo para a manufatura desses compostos, composições farmacêuticas que compreendem os mesmos, processo para o tratamento e/ou profilaxia de enfermidades e utilização dos compostos
EA200100416A1 (ru) 13-членные азалиды и их применение в качестве антибиотических агентов
HUT73433A (en) Process for preparing pharmaceutical compositions containing riluzole for treating aids-related neural disorders
BG105543A (en) Novel macrolide antibiotics
CA2047744A1 (fr) Methode de synthese de l'huperzine a et de ses analogues et composes utilises pour ce faire
WO2005000863A3 (fr) Derives d'azalides 9a 6 11-4c-bicycliques
DK0628548T3 (da) 1,2,3,4-Tetraydro-acridinamin-derivater
BR9813317A (pt) Composto, composição farmacêutica para tratar infecções bacterianas, e, processos para tratar infecções bacterianas, e para preparar um composto
BR9814498A (pt) Processo para o tratamento de obesidade em um humano necessitando de tal tratamento, composto, uso do mesmo, produto, e, composição farmacêutica
BR9912051A (pt) Uso de composto, e, processo para tratamento e prevenção de discinesia.
WO1998021213A3 (fr) Derives de 2r,4s,r,s et 2s,4r,r,s-hydroxyitraconazole et hydroxysaperconazole
IL98970A0 (en) Cyclopentane derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
BR0308837A (pt) Composto, composição, método e medicamento para o tratamento de infecções bacterianas, psorìase ou artrite em mamìferos, método e medicamento para o tratamento de toxicidade devido a quimioterapia em um paciente, composição farmacêutica, processo para a preparação de um composto e processo para a conversão dos compostos da fórmula (i) em compostos adicionais da fórmula (i)
ATE310010T1 (de) 6-0-substitutierte eryththromycin-verbindungen und verfahrenen zu ihrer herstellung
BR0214606A (pt) Processos para a preparação de derivados bicìclicos substituìdos para o tratamento de crescimento de célula anormal
YU66900A (sh) Derivati higromicina a
BRPI0416284A (pt) compostos, processo para a manufatura dos mesmos, composições farmacêuticas que os contêm, método para o tratamento e/ou prevenção de enfermidades que são moduladas por agonistas ppar(delta) e/ou ppar(alfa) e sua utilização
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
WO2002018353A3 (fr) Agents chimiotherapeutiques d'oxazolidinone

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 5A E 12A ANUIDADES.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2135 DE 06/12/2011.